期刊文献+

血管活性肠肽对重症急性胰腺炎肠屏障保护作用的实验研究 被引量:2

The protective effect of vasoactive intestinal peptide on gut barrier in severe acute pancrititis in rats
原文传递
导出
摘要 目的探讨血管活性肠肽(VIP)对重症急性胰腺炎(SAP)大鼠肠屏障的保护作用及其机制。方法54只SD大鼠随机分成3组:假手术组(SO)、SAP组和VIP干预组,采用微泵逆行胰胆管注射4%牛磺胆酸钠制备SAP动物模型,SAP制模后5min腹腔注射VIP5×10^-9nmol作为VIP干预组。各组在制模后1h、6h、12h检测血浆内毒素水平,逆转录(RT)-PCR法及免疫组化法检测肠黏膜Toll样受体4(TLR4)表达,并对肠黏膜组织行电镜检查。结果与SO组相比,SAP组血浆内毒素和肠黏膜TLR4表达在制模1h即开始增高,并随制模时间的延长而进行性增高,两者具有明显的相关性。电镜检查肠黏膜有明显的病理损伤。VIP干预组与SAP组同时点相比,血浆内毒素和肠黏膜TLR4表达降低,病理损伤减轻,制模后6h尤为明显。SO组肠黏膜未见TLR4表达。结论VIP能有效保护SAP肠屏障功能,其机制可能与下调肠黏膜TLR4的表达有关。 Objective To investigate the protective effects of vasoactive intestinal peptide(VIP) on gut barrier in rats with severe acute pancrititis (SAP) and its mechanisms. Methods Fifty four SD rats were randomly divided into sham operated (SO) group, SAP group and VIP group. The model of SAP was induced by retrograde injection of 4% sodium tauroeholate into the bili-panereatic duct. The rats in VIP group were intraperitoneal injected with VIP of 5 × 10 ^-9 nmol 5 minutes after model established . The endotoxin in plasma was measured at 1,6 and 12 hour. The expression of Toll like receptor(TLR)4 in gut mucosa was examined using RT-PCR and immunohistochemistry and mucosa tissue were detected using electroseopie examination. Results The concentration of endotoxin in plasma and expression of TLR4 were both increased at 1 hour and reached peak at 12 hour in SAP group compared with SO group(no expression of TLR4), but were decreased in VIP group. A correlation was found between endotoxin and expression of TLR4. The electroscopic examination showed that the pathological injury in intestine was severe in SAP group than that in VIP group. Conclusion The protective effect of VIP in gut barrier function may contribute to down-regulation of TLR4 expression in gut mucosa.
出处 《中华消化杂志》 CAS CSCD 北大核心 2008年第11期746-750,共5页 Chinese Journal of Digestion
关键词 血管活性肠肽 TOLL样受体4 胰腺炎 肠屏障 Vasoactive intestinal peptide, Toll-like receptor 4 Pancreatitis Gut barrier
  • 相关文献

参考文献12

  • 1Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas, 2003,26 : 122-129.
  • 2Laflamme N, Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J, 2001,15:155-163.
  • 3Yu D, Seitz PK, Selvanayagam P,et al. Effects of vasoactive intestinal peptide on adenosine 3', 5'-monophosphate, ornithine deearhoxylase, and ceil growth in a human colon cell line. Endocrinology, 1992, 131:1188-1194.
  • 4Banks MR, Farthing MJ, Robbereeht P, et al. Antisecretory actions of a novel vasoaetive intestinal polypeptide (VIP) antagonist in human and rat small intestine. Br J Pharmacol, 2005,144:994-1001.
  • 5Milner P, Crowe R, Kamm MA, et al. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and divertieular disease. Gastroenterology, 1999,99 : 666-675.
  • 6Lankisch PG, Ihse I. Bile-induced acute experimental panereatitis. Scand J Gastroenterol, 1987,22 : 257-260.
  • 7Hietaranta A, Mustonen Proinflammatory effects of H, Puolakkainen P, et al. pancreatic elastase are mediated through TLR4 and NF kappaB. Biochem Biophys Res Commun, 2004,323:192-196.
  • 8Hashimoto N, Ohyanagi H. Effect of acute portal hypertension on gut mueosa. Hepatogastroenterology, 2002.49:1567-1570.
  • 9PenalvaJC, Martinez J, Laveda R, et al. A study of intestinal permeability in relation to the inflammatory response and plasma endoeab IgM levels in patients with acute pancreatitis. J Clin Gastroenterol, 2004,38:512-517.
  • 10Wang X, Gong Z. Wu K. et al. Gastrointestinal dysmotility in patients with acute pancreatitis. J Gastroenterol Hepatol, 2003,18:57-62.

同被引文献41

  • 1罗德劲,赵小玲,吴志钢,鞠忠玲,欧阳林静.再发性腹痛患儿血浆P物质和血管活性肠肽水平分析[J].中国误诊学杂志,2009,9(1):43-44. 被引量:7
  • 2朱金照,许其增.肝硬化大鼠肠道动力的变化及机制[J].胃肠病学和肝病学杂志,2005,14(2):150-152. 被引量:12
  • 3潘延凤,秦涛,周蓉,武淑环.VIP在慢性丙型肝炎病毒感染中的表达及意义[J].山东医药,2007,47(1):61-61. 被引量:2
  • 4袁楚明,陈梦云,李奕琏,陈健芳.早期应用生大黄对重症急性胰腺炎的疗效[J].胰腺病学,2007,7(1):31-33. 被引量:20
  • 5Lee JC, Cho YJ, Kim J, et al. Region - specific changes in the immunoreactivity of vasoactive intestinal peptide and pituitary adenylate cyclase - activating polypeptide receptors (VPAC2, and PAC1 receptor) in the aged rat brains [J]. Brain Res, 2010, 1351 (1) : 32 -40.
  • 6Tompkins JD, Girard BM, Vizzard MA, et al. VIP and PACAP effects on mouse major pelvic ganglia neurons [J]. J Mol Neurosci, 2010, 42 (3): 390-396.
  • 7Kasparek MS, Fatima J, Iqbal CW, et al. Effect of chronic, extrinsic denervation on functional NANC innervation with vasoactive intestinal polypeptide and substance P in longitudinal muscle of rat jejunum [J]. Neurogastroenterol Motil, 2008, 20 (3) : 243 -252.
  • 8Kellogg DLJr, ZhaoJL, Wu Y, etal. VIP! PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans [ J]. J Appl Physiol, 2010, 109 (1) : 95 - 100.
  • 9Moody TW, Ito T, Osefo N, et al. VIP and PACAP: recent insights into their functions/ roles in physiology and disease from molecular and genetic studies [ J ]. Curr Opin Endocrinol Diabetes Obes, 2011, 18 (1) : 61 -67.
  • 10Oshima T, Miwa H. Pathogenesis of gastro - esophageal reflux disease [ J ]. Nippon Rinsho, 2007, 65 (5): 797-801.

引证文献2

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部